Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Rogaratinib is a potent and selective pan-fibroblast growth factor receptor (FGFR) tyrosine kinase inhibitor with broad antitumor activity in FGFR-overexpressing preclinical cancer models. It is an investigational drug that may treat different types of cancer, including Non-Small-Cell Lung Carcinoma (NSCLC) (FGFR m), Small-cell-lung-cancer (SCLC) (FGFR m), Bladder Cancer (FGFR m), Head & Neck cancer (FGFR m), and [Breast Cancer /…